Deane Rhodes

Insider Reports History

Location
Tuscaloosa, AL
Signature
/s/ Deane Rhodes
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Deane Rhodes:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Immune Therapeutics, Inc. Member of 10% owner group Common Stock 100 $5.00 $0.05 28 May 2021 Direct

Insider Reports Filed by Deane Rhodes

Symbol Company Period Transactions Value $ Form Type Role Filing Time
IMUN Immune Therapeutics, Inc. 28 May 2021 0 $0 3 Member of 10% owner group 07 Jun 2021, 06:45